Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-01 King-Jones Heidy See Remarks Option exercise 10b5-1 +28,933 $14.50 $420K 31,778
2026-10-01 King-Jones Heidy See Remarks Sale 10b5-1 −400 $89.24 $36K 31,378
2026-10-01 King-Jones Heidy See Remarks Sale 10b5-1 −16,605 $90.35 $1.5M 14,773
2026-10-01 King-Jones Heidy See Remarks Sale 10b5-1 −7,228 $91.35 $660K 7,545
2026-10-01 King-Jones Heidy See Remarks Sale 10b5-1 −2,100 $92.70 $195K 5,445
2026-10-01 King-Jones Heidy See Remarks Sale 10b5-1 −2,600 $93.46 $243K 2,845
2026-10-01 King-Jones Heidy See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −28,933 482,478
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −600 $89.14 $53K 551,940
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −2,683 $90.10 $242K 549,257
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −2,638 $91.49 $241K 546,619
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −3,989 $92.31 $368K 542,630
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −4,990 $93.37 $466K 537,640
2026-10-01 Turtle Cameron Chief Executive Officer Sale 10b5-1 −100 $93.91 $9K 537,540
2026-10-01 Burrows Scott L Chief Financial Officer Option exercise 10b5-1 +7,500 $14.50 $109K 87,262
2026-10-01 Burrows Scott L Chief Financial Officer Sale 10b5-1 −600 $89.07 $53K 86,662
2026-10-01 Burrows Scott L Chief Financial Officer Sale 10b5-1 −1,500 $90.27 $135K 85,162
2026-10-01 Burrows Scott L Chief Financial Officer Sale 10b5-1 −2,100 $91.92 $193K 83,062
2026-10-01 Burrows Scott L Chief Financial Officer Sale 10b5-1 −3,071 $92.95 $285K 79,991
2026-10-01 Burrows Scott L Chief Financial Officer Sale 10b5-1 −229 $93.57 $21K 79,762
2026-10-01 Burrows Scott L Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −7,500 312,357

Page 1 of 19 · 372 trades